Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Tolnaftate
Scholl Consumer Products Limited
D01AE; D01AE18
Tolnaftate
1 percent weight/weight
Cream
Product not subject to medical prescription
Other antifungals for topical use; tolnaftate
Not marketed
1986-11-19
Reckitt Benckiser 0003 PA 455/1/2 CCDS Update Scholl Athletes Foot Powder 1% w/w Page 1 ATHLETE’S FOOT CREAM TOLNAFTATE 1% W/W ANTI-FUNGUS TREATS ATHLETE’S FOOT FUNGI Read all of this leaflet carefully before you start using this medicine because it contains important information for you. What is in this leaflet: 1. What Scholl Athlete’s Foot Cream is and what it is used for 2. What you need to know before you use Scholl Athlete’s Foot Cream 3. How to use Scholl Athlete’s Foot Cream 4. Possible Side Effects 5. How to store Scholl Athlete’s Foot Cream 6. Contents of the pack and other information 1. WHAT SCHOLL ATHLETE’S FOOT CREAM IS AND WHAT IT IS USED FOR Scholl Athlete’s Foot Cream is a topical antifungal for the treatment of Athlete’s Foot. It contains Tolnaftate antifungal, an effective antifungal medication available without prescription for treating Athlete’s Foot Fungi. 2. BEFORE YOU USE SCHOLL ATHLETE’S FOOT CREAM Do not use... • if you are allergic to Tolnaftate or any of the other ingredients of this medicine listed in Section 6 • for nail and scalp infections Warnings and Precautions: Keep this leaflet - you may need to refer to it again. This product contains: butylhydroxytoluene (E321), cetosteary alcohol and chlorocresol which may cause allergic reactions, local skin reactions (e.g. contact dermatitis) or irritation to the eyes and mucous membranes 3. HOW TO USE SCHOLL ATHLETE’S FOOT CREAM Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. For External Use Only • Wash and dry infected area and apply liberally twice each day, or as directed by a doctor. • If seal on tube is broken do not use. • Wear clean socks or hosiery every day. • Continue for two weeks after symptoms disappear. • If symptoms do not improve within 10 days, stop use and speak to your doctor. 4. POSSIBLE SIDE EFFECTS 1.3.1 Pa L ck i a k g e e a Le ll af m let e - d C i r c ea in m Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Scholl Athlete’s Foot Cream. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Tolnaftate 1.00% w/w Excipients: Butylated Hydroxytoluene (E321) 0.002% w/w Chlorocresol 0.1% w/w Cetostearyl alcohol 7.2% w/w For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Cream. Smooth, white, odourless cream. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As a fungistat in the topical treatment of infections due to dermatophytes sensitive to this agent including microspore, epidermophyta and trichophyta. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY: Adults: Apply to the affected area twice daily or as directed by a doctor. Continue treatment for two weeks after symptoms disappear. Paediatric population: As above for adults. METHOD OF ADMINISTRATION: Topical application only. Wash and dry the infected before applying.. Wear clean socks or hosiery. Apply liberally. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in Section 6.1. Contraindicated in nail or scalp infections. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE For external use only. Keep out of eyes. If irritation or rash continues, use of the product should be discontinued and medical advice should be sought. If symptoms do not improve within 10 days, discontinue use and consult your doctor. Contains chlorocresol. May cause allergic reactions. Also contains butylhydroxytolune (E321) and cetostearyl alcohol. May cause local skin reactions (e.g. contact dermatitis), or irritation to the eyes and muscos membranes. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION Not applicable. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ Read the complete document